Bioavailability Enhancement

Salvatore Mercuri, Ph.D.

Salvatore Mercuri serves as head of Research and Development at Lonza's site in Monteggio, Switzerland, which is Lonza's European Center for Excellence for Particle Engineering, specializing in particle size control through micronization. Salvatore's expertise includes the development of highly potent active pharmaceutical ingredients (HPAPIs) and the formulation of of modified-release solid oral dosage forms. He joined Micro-Macinazione SA in 2013, prior to its acquisition by Lonza, and has held positions of increasing authority. Salvatore graduated with a degree in Industrial Pharmacy before earning his Ph.D. in Biopharmaceutics and Pharmacokinetics, both from the University of Parma. He completed postdoctoral work in the Department of Pharmacy at the University of Parma, focusing on modified-release dosage forms.

Watch interview

Meet Salvatore

In this short video, Salvatore explains how his team develops new solutions and technologies to meet the micronization needs of our customers.

Content by this expert

Meet Salvatore

Recently published by Salvatore

Particle Size Control Through Micronization: Challenges and Solutions

How To Deal With A Difficult To Micronize Drug Substance